MedTech Dive June 18, 2024
Susan Kelly

Silk Road developed a minimally invasive procedure to prevent stroke in patients with carotid artery disease.

Dive Brief:

  • Boston Scientific has agreed to acquire Silk Road Medical, a maker of stroke prevention devices, for $27.50 per share in cash, or an equity value of about $1.26 billion, the companies said Tuesday.
  • Silk Road’s products are the only commercially available devices for use during a minimally invasive procedure called transcarotid artery revascularization (TCAR) to treat patients with carotid artery disease, according to Boston Scientific.
  • “We view the deal as largely inexpensive for Boston yet meaningful enough to move the needle on growth in the peripheral interventions business,” J.P. Morgan analyst Robbie Marcus said in a note to clients.


Today's Sponsors


Today's Sponsor


Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Danaher setting up labs to support companion diagnostic development
Q Bio Secures $27M to Expand Full-Body MRI with Mark I Scanner
Advanced diagnostics: Patient-centered innovation
GE HealthCare to acquire clinical AI company in $51M deal
Abbott previews PFA, over-the-counter CGM markets

Share This Article